Marielena Mata
- Oncology top 10%
- Pulmonary and Respiratory Medicine top 10%
- Molecular Biology
- Cancer Research
- Immunology and Allergy
- Co-authors
- Karim FizaziFred SaadCelestia S. HiganoNiven MehraHsiang-Chun ChenAkos CzibereJohann S. de BonoCynthia G. Healy
- Topics
- PARP inhibition in cancer therapy (8 papers)Prostate Cancer Treatment and Research (6 papers)Cancer Genomics and Diagnostics (5 papers)
- Partner nations
- United StatesItalyUnited Kingdom
In The Last Decade
Marielena Mata
17 papers receiving 360 citations
Hit Papers
Peers
Comparison fields: 5 of 49
- Oncology 256
- Pulmonary and Respiratory Medicine 201
- Molecular Biology 179
- Cancer Research 72
- Immunology and Allergy 41
Countries citing papers authored by Marielena Mata
This map shows the geographic impact of Marielena Mata's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Marielena Mata with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Marielena Mata more than expected).
Fields of papers citing papers by Marielena Mata
This network shows the impact of papers produced by Marielena Mata. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Marielena Mata. The network helps show where Marielena Mata may publish in the future.
Co-authorship network of co-authors of Marielena Mata
This figure shows the co-authorship network connecting the top 25 collaborators of Marielena Mata. A scholar is included among the top collaborators of Marielena Mata based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Marielena Mata. Marielena Mata is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 8 | |
| 2 | 3 | |
| 3 | Talazoparib monotherapy in metastatic castration-resistant prostate cancer with DNA repair alterations (TALAPRO-1): an open-label, phase 2 trialbreakdown → | 183 |
| 4 | 3 | |
| 5 | 8 | |
| 6 | 2 | |
| 7 | 34 | |
| 8 | 16 | |
| 9 | 32 | |
| 10 | 2 | |
| 11 | 2 | |
| 12 | 4 | |
| 13 | 22 | |
| 14 | 10 | |
| 15 | 3 | |
| 16 | 35 | |
| 17 | 4 |
About Marielena Mata
Marielena Mata is a scholar working on Cancer Research, Oncology and Immunology and Allergy, having authored 17 papers that have together received 371 indexed citations. Recurring topics across this work include PARP inhibition in cancer therapy (8 papers), Prostate Cancer Treatment and Research (6 papers) and Cancer Genomics and Diagnostics (5 papers). The work is most often cited by research in Oncology (256 citations), Immunology and Allergy (41 citations) and Pulmonary and Respiratory Medicine (201 citations). Marielena Mata has collaborated with scholars based in United States, Italy and United Kingdom. Frequent co-authors include Karim Fizazi, Fred Saad, Celestia S. Higano, Niven Mehra, Hsiang-Chun Chen, Akos Czibere, Johann S. de Bono, Cynthia G. Healy, Consuelo Buttigliero and Inge M. van Oort. Their work appears in journals such as Journal of Clinical Oncology, Blood and Cancer Research.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.